Progression-free survival as surrogate endpoint for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer

S. Michiels, L. Pugliano, S. Marguet, D. Grun, J. Barinoff, David Cameron, M. Cobleigh, A. Di Leo, S. Johnston, G. Gasparini, B. Kaufman, M. Marty, V. Nekjudova, S. Paluch-Shimon, F. Penault-Llorca, D. Slamon, C. Vogel, G. Von Minckwitz, M. Buyse, M. Piccart

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalAnnals of Oncology
Publication statusPublished - 8 Mar 2016

Cite this